62 related articles for article (PubMed ID: 2807152)
21. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
Johnson TL; Lloyd RV; Thor A
Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
[TBL] [Abstract][Full Text] [Related]
22. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
[TBL] [Abstract][Full Text] [Related]
23. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
24. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
[TBL] [Abstract][Full Text] [Related]
25. [Ultrastructural characteristics of thyroid medullary carcinoma].
Raĭkhlin NT; Smirnova EA; Satylganov IZh
Arkh Patol; 2001; 63(4):13-8. PubMed ID: 11534184
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors of survival in medullary cancers of the thyroid. Apropos of 51 cases. Clinical, biochemical and immunocytochemical study].
Goudet P; Rogissart F; Petit JM; Vaillant G; Durnerin I; Fraisse J; Justrabo E; Verges B; Cougard P
Ann Chir; 1996; 50(1):23-9. PubMed ID: 8734273
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
28. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
30. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of nuclear morphometry in follicular carcinoma of the thyroid gland].
Palestini N; Cappello N; Durando R; Festini-Mira I; Framarin L; Abeatici S
Ann Ital Chir; 1994; 65(1):69-73; discussion 74. PubMed ID: 7978748
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
34. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 expression in primary thyroid carcinomas.
Sporny S; Slowinska-Klencka D; Ratynska M
Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
[TBL] [Abstract][Full Text] [Related]
36. [Low-risk thyroid carcinoma--therapy, follow-up and prognosis].
Sophocleous S; Ehrenheim C; Fischer J; Hundeshagen H
Nuklearmedizin; 1997 Apr; 36(3):93-102. PubMed ID: 9162908
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Virchows Arch A Pathol Anat Histopathol; 1987; 411(5):435-9. PubMed ID: 3116758
[TBL] [Abstract][Full Text] [Related]
38. Nuclear DNA content and prognosis in Hürthle cell tumours of the thyroid gland.
Wallin G; Bäckdahl M; Lundell G; Auer G; Löwhagen T
Acta Chir Scand; 1988 Sep; 154(9):501-4. PubMed ID: 3201861
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of nuclear DNA content in medullary thyroid carcinoma; a retrospective pilot study.
Tallroth E; Bäckdahl M; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T
Radiother Oncol; 1985 Nov; 4(3):225-30. PubMed ID: 4081112
[TBL] [Abstract][Full Text] [Related]
40. Re: Prognostic factors in medullary carcinoma of the thyroid.
Soares J; Fonseca I; Limbert E
Surgery; 1993 Feb; 113(2):236. PubMed ID: 8430374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
